"A Multihemo foi fundada em 2000, no Recife, por um grupo de médicos comprometidos em oferecer serviços de qualidade em hematologia e hemoterapia. Hoje, oferecemos excelência em toda a nossa linha de cuidados. Contamos com um corpo clínico altamente qualificado em hematologia clínica, onco-hematologia, oncologia clínica, mastologia e urologia, e com uma equipe multidisciplinar com especialistas em nutrição, psicologia e enfermagem oncológica e farmácia clínica. Profissionais comprometidos em acolher o paciente e seus familiares com integridade, proximidade e responsabilidade."

During the past decade, MultiHemo conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MultiHemo" are "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Metastatic Prostate Cancer" (1 trials), "Transfusion-dependent Alpha-Thalassemia" (1 trials), "Transfusion-dependent Beta-Thalassemia" (1 trials) and "Warm Autoimmune Hemolytic Anemia" (1 trials). Many other conditions were trialed in "MultiHemo" in a lesser frequency.

Most popular intervention types in "MultiHemo" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "M281" (1 trials), "Mitapivat" (1 trials), "Niraparib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "MultiHemo" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "MultiHemo". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MultiHemo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MultiHemo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".